Deficit of in vivo mitochondrial ATP production in OPA1‐related dominant optic atrophy

Dominant optic atrophy has been associated with mutations in the OPA1 gene, which encodes for a dynamin‐related GTPase, a mitochondrial protein implicated in the formation and maintenance of mitochondrial network and morphology. We used phosphorus magnetic resonance spectroscopy to assess calf muscle oxidative metabolism in six patients from two unrelated families carrying the c.2708‐2711delTTAG deletion in exon 27 of the OPA1 gene. The rate of postexercise phosphocreatine resynthesis, a measure of mitochondrial adenosine triphosphate production rate, was significantly delayed in the patients. Our in vivo results show for the first time to our knowledge a deficit of oxidative phosphorylation in OPA1‐related DOA. Ann Neurol 2004;56:719–723

[1]  V. Carelli,et al.  Mitochondrial dysfunction as a cause of optic neuropathies , 2004, Progress in Retinal and Eye Research.

[2]  J. Parisi,et al.  Paraneoplastic autoimmune optic neuritis with retinitis defined by CRMP‐5‐IgG , 2003, Annals of neurology.

[3]  G. Lenaers,et al.  Loss of OPA1 Perturbates the Mitochondrial Inner Membrane Structure and Integrity, Leading to Cytochrome c Release and Apoptosis* , 2003, The Journal of Biological Chemistry.

[4]  A. Schapira,et al.  Leber's Hereditary Optic Neuropathy (LHON) Pathogenic Mutations Induce Mitochondrial-dependent Apoptotic Death in Transmitochondrial Cells Incubated with Galactose Medium* , 2003, The Journal of Biological Chemistry.

[5]  T. Hamamoto,et al.  Differential sublocalization of the dynamin-related protein OPA1 isoforms in mitochondria. , 2003, Biochemical and biophysical research communications.

[6]  G. Lenaers,et al.  The human dynamin‐related protein OPA1 is anchored to the mitochondrial inner membrane facing the inter‐membrane space , 2002, FEBS letters.

[7]  G. Lenaers,et al.  OPA1 (Kjer type) dominant optic atrophy: a novel mitochondrial disease. , 2002, Molecular genetics and metabolism.

[8]  B. Lorenz,et al.  Mutation spectrum and splicing variants in the OPA1 gene , 2001, Human Genetics.

[9]  K. Chan,et al.  ANNA‐3 anti‐neuronal nuclear antibody: Marker of lung cancer‐related autoimmunity , 2001, Annals of neurology.

[10]  D. Manners,et al.  No correlation between muscle A3243G mutation load and mitochondrial function in vivo , 2001, Neurology.

[11]  M. Magistris,et al.  Paraneoplastic anti‐CV2 antibodies react with peripheral nerve and are associated with a mixed axonal and demyelinating peripheral neuropathy , 2001, Annals of neurology.

[12]  E. Benarroch,et al.  CRMP‐5 neuronal autoantibody: Marker of lung cancer and thymoma‐related autoimmunity , 2001, Annals of neurology.

[13]  J. Grosgeorge,et al.  Nuclear gene OPA1, encoding a mitochondrial dynamin-related protein, is mutated in dominant optic atrophy , 2000, Nature Genetics.

[14]  S. Bhattacharya,et al.  OPA1, encoding a dynamin-related GTPase, is mutated in autosomal dominant optic atrophy linked to chromosome 3q28 , 2000, Nature Genetics.

[15]  B. Barbiroli,et al.  'Secondary' 4216/ND1 and 13708/ND5 Leber's hereditary optic neuropathy mitochondrial DNA mutations do not further impair in vivo mitochondrial oxidative metabolism when associated with the 11778/ND4 mitochondrial DNA mutation. , 2000, Brain : a journal of neurology.

[16]  V. Lennon,et al.  New Purkinje cell antibody (PCA‐2): Marker of lung cancer–related neurological autoimmunity , 2000, Annals of neurology.

[17]  J. Sloan,et al.  Neuronal autoantibody titers in the course of small-cell lung carcinoma and platinum-associated neuropathy , 1999, Cancer Immunology, Immunotherapy.

[18]  Loise M. Francisco,et al.  Tumor-specific killer cells in paraneoplastic cerebellar degeneration , 1998, Nature Medicine.

[19]  B. Ducommun,et al.  Identification of a fission yeast dynamin-related protein involved in mitochondrial DNA maintenance. , 1998, Biochemical and biophysical research communications.

[20]  V. Lennon,et al.  Neuronal calcium channel autoantibodies coexisting with type 1 Purkinje cell cytoplasmic autoantibodies (PCA-1 or "anti-Yo") , 1998, Neurology.

[21]  V. Lennon,et al.  Neuronal nicotinic ACh receptor antibody in subacute autonomic neuropathy and cancer‐related syndromes , 1998, Neurology.

[22]  G. Radda,et al.  In vivo skeletal muscle mitochondrial function in Leber's hereditary optic neuropathy assessed by 31P magnetic resonance spectroscopy , 1997, Annals of neurology.

[23]  E. Dropcho.  Antiamphiphysin antibodies with small‐cell lung carcinoma and paraneoplastic encephalomyelitis , 1996, Annals of neurology.

[24]  V. Lennon.  Calcium Channel and Related Paraneoplastic Disease Autoantibodies , 1996 .

[25]  P. Zaniol,et al.  Defective brain and muscle energy metabolism shown by in vivo 31P magnetic resonance spectroscopy in nonaffected carriers of 11778 mtDNA mutation , 1995, Neurology.

[26]  P. Zaniol,et al.  in vivo assessment of mitochondrial functionality in human gastrocnemius muscle by 31P MRS. The role of pH in the evaluation of phosphocreatine and inorganic phosphate recoveries from exercise , 1993, NMR in biomedicine.

[27]  A. Engel,et al.  Passive transfer of Lambert-Eaton myasthenic syndrome with IgG from man to mouse depletes the presynaptic membrane active zones. , 1983, Proceedings of the National Academy of Sciences of the United States of America.

[28]  L. Klinken,et al.  HISTOPATHOLOGY OF EYE, OPTIC NERVE AND BRAIN IN A CASE OF DOMINANT OPTIC ATROPHY , 1983, Acta ophthalmologica.

[29]  V. Smith,et al.  A clinicopathologic study of autosomal dominant optic atrophy. , 1979, American journal of ophthalmology.

[30]  H A Krebs,et al.  Cytosolic phosphorylation potential. , 1979, The Journal of biological chemistry.

[31]  P. Kjer.  Infantile optic atrophy with dominant mode of inheritance: a clinical and genetic study of 19 Danish families. , 1959, Acta ophthalmologica. Supplementum.